JACOBSON PHARMA(02633.HK): FY 25/26 Annual Report - Profit Attributable to Shareholders stood at HKD 301.62 million, YoY increase of 0.26%

NewTimeSpace (newtimespace.com) News, June 23, 2026, JACOBSON PHARMA(02633.HK) released its Annual Report for the period ended March 31, 2026, Total Revenue stood at HKD 1.57 billion, decreased by 0.47% YoY; Net Profit stood at HKD 301.62 million, YoY increase of 0.26%; Profit Attributable to Shareholders stood at HKD 301.62 million, YoY increase of 0.26%; Basic Earnings Per Share (EPS) stood at HKD 0.15.
In terms of profitability, JACOBSON PHARMA Gross Profit changed from HKD 692.94 million in the same period last year to HKD 677.9 million in the current period, decreased by HKD 15.04 million; gross profit margin changed from 43.94% in the same period last year to 43.19% in the current period, decreased by 0.75 percentage points; net profit changed from HKD 300.83 million in the same period last year to HKD 301.62 million in the current period, increased by HKD 784 thousand; net profit margin changed from 19.08% in the same period last year to 19.22% in the current period, increased by 0.14 percentage points.
In terms of earnings quality, JACOBSON PHARMA Operating Profit changed from HKD 414.6 million in the same period last year to HKD 388.65 million in the current period, decreased by HKD 25.95 million; Operating Profit Margin changed from 26.29% in the same period last year to 24.76% in the current period, decreased by 1.53 percentage points.
In terms of financial soundness, JACOBSON PHARMA Debt-to-Asset Ratio changed from 32.03% in the same period last year to 34.34% in the current period, increased by 2.3 percentage points; Total Equity changed from HKD 2.477 billion in the same period last year to HKD 2.34 billion in the current period, decreased by HKD 137.23 million; Current Liabilities changed from HKD 553.14 million in the same period last year to HKD 717.45 million in the current period, increased by HKD 164.31 million; Quick Ratio changed from 1.27 in the same period last year to 0.86 in the current period, decreased by 0.41 percentage points.
By the close of trading on June 23, 2026, JACOBSON PHARMA(02633) saw a loss of 2.73% in its share price, closing at HKD 1.07. The full-day turnover stood at HKD 361.56 thousand, with the latest market capitalization at HKD 2.14 billion.

NewTimeSpace Disclaimer:All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.